Image

Global Pituitary Dwarf Treatment Market – Industry Trends and Forecast to 2030

Pharmaceutical

Image

Global Pituitary Dwarf Treatment Market – Industry Trends and Forecast to 2030

  • Pharmaceutical
  • Upcoming Report
  • Dec 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Pituitary Dwarf Treatment Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 4.90 USD Billion
Diagram Market Size (Forecast Year) USD 14.48 USD Billion
Diagram CAGR %

Major Markets Players

  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

Global Pituitary Dwarf Treatment Market, By Types (Pituitary Dwarfism Type I, Pituitary Dwarfism Type II, Pituitary Dwarfism Type III, Pituitary Dwarfism Type IV, Others), Treatment (Surgery, Additional Therapy, Drugs, Others), Route of Administration (Parenteral, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2030.

Pituitary Dwarf Treatment Market

 Pituitary Dwarf Treatment Market Analysis and Size

Pituitary dwarfism may vary worldwide, usually from 1:30,000 to 1:1800. The demand for the market is increasing rapidly, primarily because of increasing cases of pituitary dysfunction that leads to deficiency of the growth hormone. In adults, the growth hormone deficiency may lead to decreased energy, depressed mood, extreme fatigue, decreased muscle strength, muscle mass, thin and dry skin, increased adipose tissue, and reduced bone density.

Data Bridge Market Research analyses a growth rate in pituitary dwarf treatment market in the forecast period 2023-2030. The expected CAGR of pituitary dwarf treatment market is tend to be around 14.50% in the mentioned forecast period. The market was valued at USD 4.9 billion in 2022, and it would grow upto USD 14.48 billion by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Pituitary Dwarf Treatment Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023-2030

Base Year

2022

Historic Years

2021 (Customizable to 2015 - 2020)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Types (Pituitary Dwarfism Type I, Pituitary Dwarfism Type II, Pituitary Dwarfism Type III, Pituitary Dwarfism Type IV, Others), Treatment (Surgery, Additional Therapy, Drugs, Others), Route of Administration (Parenteral, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Teva Pharmaceutical Industries Ltd (Israel), Apotex Inc (Canada), Armata Pharmaceuticals, Inc. (U.S.), Pfizer Inc (U.S.), H. Lundbeck A/S (Denmark), Alterity Therapeutics (Australia), Vertex Pharmaceuticals Incorporated (U.S.), Lilly (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Mylan N.V. (U.S.)

Market Opportunities

  • Growing Demand of Different Treatment Methods

Market Definition

Pituitary dwarf is also known as growth hormone deficiency disorder. It is the type of condition wherein pituitary gland does not produce enough growth hormone, resulting in a child's slow growth pattern. Various symptoms include chubby body build, immature appearance, prominent forehead, below-average growth, and underdeveloped bridge of the nose among others. This condition starts emerging in childhood itself and becomes even more prominent when the child reaches puberty. The growth and development of the child slows down or gets delayed.

Pituitary Dwarf Treatment Market Dynamics

Drivers

  • Increasing Demands of Diagnostic Tests

There are various diagnostic tests that are boosting the demand of the market. Several imaging tests such as X-rays are used as certain abnormalities of the skull and skeleton can specify the disorder the patient has. Numerous imaging devices may also show delayed maturation of bones, as is the case in growth hormone deficiency. A magnetic resonance imaging (MRI) scan may show abnormalities of the pituitary gland or hypothalamus, both of which play a major role in hormone function.  

Opportunities

  •  Growing Demand of Different Treatment Methods

There are numerous treatment methods that are aiding in boosting the growth of the market. Subcutaneous injections are being provided on a daily basis as the dose of hormone therapy until the child finally reached an appropriate height. In girls, hormones such as estrogen and progesterone are added, on the other hand in boys, testosterone is added. Testosterone must be added very carefully as it can have a huge effect on children. Other drugs can also be used to surge the production of growth hormones. Drugs such as arginine, chlonidine, propranolol, and dopamine can be used efficiently. Other anabolic substances such as nandrolone, oxandrolone and fluoxinesterone, help in the stimulation of protein synthesis. This also increases cartilage and bone growth.

 Restraints/Challenges

  • Side Effects of Pituitary Dwarf Treatment

The pituitary dwarf treatment is involved with several side effects such as rash and pain at the sight of the injection, transient fever, edema, increased insulin resistance and other such problems. This hampers the market growth.

  • Discontinuation of Drug Trials

The drug development for the disease has faced major obstacles as numerous therapies have failed to demonstrate efficacy or were associated with major toxicity. Thus, this hampers the growth of the market.

This pituitary dwarf treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the pituitary dwarf treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments:

  • In 2021, Biocorp and Merck joined hands in the development and global distribution of a specific version of the Mallya device for applications in the field of HGH.
  • In 2020, US FDA approved Novo Nordisk, Inc.’s Sogroya (somapacitan), as the first human growth hormone (HGH) therapy that adult patients only take once a week by injection under the skin

Global Pituitary Dwarf Treatment Market Scope

The pituitary dwarf treatment market is segmented on the basis of treatment, types, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Types

  • Pituitary Dwarfism Type I
  • Pituitary Dwarfism Type II
  • Pituitary Dwarfism Type III
  • Pituitary Dwarfism Type IV
  • Others

Treatment

  • Surgery
  • Additional Therapy
  • Drugs
  • Others

Route of Administration

  • Parenteral
  • Others

End User

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

 Pituitary Dwarf Treatment Market Regional Analysis/Insights

The pituitary dwarf treatment market is analyzed and market size insights and trends are provided by treatment, type, route of administration, distribution channel and end-user as referenced above.

The major countries covered in the pituitary dwarf treatment market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Asia-Pacific will be expecting positive growth for pituitary dwarf treatment market throughout the forecasted period due to the continuously increasing population resulting increasing prevalence of dwarfism and other growth hormone deficiency disorders.

North America dominates the market due to increased government awareness programs, advanced technology and treatment. 

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Pituitary Dwarf Treatment Market Share Analysis

The pituitary dwarf treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to pituitary dwarf treatment market.

Key players operating in the pituitary dwarf treatment market include:

  • Teva Pharmaceutical Industries Ltd (Israel)
  • Amneal Pharmaceuticals LLC. (U.S.)
  • Elekta AB (Sweden)
  • Alnylam Pharmaceuticals, Inc (U.S.)
  • Apotex Inc (Canada)
  • Armata Pharmaceuticals, Inc. (U.S.)
  • Pfizer Inc (U.S.)
  • H. Lundbeck A/S (Denmark)
  • Lilly (U.S.)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Mylan N.V. (U.S.)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

FREQUENTLY ASK QUESTIONS

The Pituitary Dwarf Treatment Market is projected to grow at a CAGR of 14.50% during the forecast period by 2030.
The future market value of the Pituitary Dwarf Treatment Market is expected to reach USD 14.48 billion by 2030.
The major players in the Pituitary Dwarf Treatment Market are Teva Pharmaceutical Industries Ltd (Israel), Apotex Inc (Canada), Armata Pharmaceuticals, Inc. (U.S.), Pfizer Inc (U.S.), H. Lundbeck A/S (Denmark), Alterity Therapeutics (Australia), etc.
The countries covered in the Pituitary Dwarf Treatment Market are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, etc.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials